OtherArticle
KU135, a Novel Novobiocin-derived C-terminal Inhibitor of Hsp90, Exerts Potent Antiproliferative Effects in Human Leukemic Cells
Shary N Shelton, Mary E Shawgo, Shawna B Comer, Yuanming Lu, Alison C Donnelly, Kristen Szabla, Mehmet Tanol, George A Vielhauer, Roger A Rajewski, Robert L Matts, Brian S J Blagg and John D Robertson
Molecular Pharmacology September 9, 2009, DOI: https://doi.org/10.1124/mol.109.058545
Shary N Shelton
Mary E Shawgo
Shawna B Comer
Yuanming Lu
Alison C Donnelly
Kristen Szabla
Mehmet Tanol
George A Vielhauer
Roger A Rajewski
Robert L Matts
Brian S J Blagg
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
KU135, a Novel Novobiocin-derived C-terminal Inhibitor of Hsp90, Exerts Potent Antiproliferative Effects in Human Leukemic Cells
Shary N Shelton, Mary E Shawgo, Shawna B Comer, Yuanming Lu, Alison C Donnelly, Kristen Szabla, Mehmet Tanol, George A Vielhauer, Roger A Rajewski, Robert L Matts, Brian S J Blagg and John D Robertson
Molecular Pharmacology September 9, 2009, DOI: https://doi.org/10.1124/mol.109.058545
OtherArticle
KU135, a Novel Novobiocin-derived C-terminal Inhibitor of Hsp90, Exerts Potent Antiproliferative Effects in Human Leukemic Cells
Shary N Shelton, Mary E Shawgo, Shawna B Comer, Yuanming Lu, Alison C Donnelly, Kristen Szabla, Mehmet Tanol, George A Vielhauer, Roger A Rajewski, Robert L Matts, Brian S J Blagg and John D Robertson
Molecular Pharmacology September 9, 2009, DOI: https://doi.org/10.1124/mol.109.058545
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement